These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24866986)

  • 41. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials.
    Trifirò G; Alacqua M; Corrao S; Tari M; Arcoraci V
    J Am Geriatr Soc; 2008 Jan; 56(1):175-7. PubMed ID: 18184214
    [No Abstract]   [Full Text] [Related]  

  • 42. Statin use and risk of pancreatic cancer: a meta-analysis.
    Cui X; Xie Y; Chen M; Li J; Liao X; Shen J; Shi M; Li W; Zheng H; Jiang B
    Cancer Causes Control; 2012 Jul; 23(7):1099-111. PubMed ID: 22562222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The care gap: underuse of statin therapy in the elderly.
    Gaw A
    Int J Clin Pract; 2004 Aug; 58(8):777-85. PubMed ID: 15372851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of statin therapy in elderly.
    Ginter E; Kajaba I
    Bratisl Lek Listy; 2016; 117(10):555-556. PubMed ID: 27826969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Safety of statins].
    Oscanoa Espinoza TJ; Paredes-Pérez N; Lizaraso-Soto F
    Rev Fac Cien Med Univ Nac Cordoba; 2016; 73(4):263-278. PubMed ID: 28152368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Debate on adverse effects of statins.
    Bifulco M
    Eur J Intern Med; 2014 Oct; 25(8):e95. PubMed ID: 25216633
    [No Abstract]   [Full Text] [Related]  

  • 47. Is it time for a cardiovascular primary prevention trial in the elderly?
    Robinson JG; Bakris G; Torner J; Stone NJ; Wallace R
    Stroke; 2007 Feb; 38(2):441-50. PubMed ID: 17194877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analyses of statin trials: clear benefit for primary prevention in the elderly.
    Waters DD
    J Am Coll Cardiol; 2013 Dec; 62(22):2100-1. PubMed ID: 23994398
    [No Abstract]   [Full Text] [Related]  

  • 49. What is the role of statins in the elderly population?
    Stavropoulos K; Imprialos K; Doumas M; Athyros VG
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):329-331. PubMed ID: 29431524
    [No Abstract]   [Full Text] [Related]  

  • 50. [Some questions about statins].
    Dangoumau J; Haramburu F; Bégaud B
    Therapie; 2003; 58(1):91-5. PubMed ID: 12822206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statins in the elderly: a patient-focused approach.
    Wilmot KA; Khan A; Krishnan S; Eapen DJ; Sperling L
    Clin Cardiol; 2015 Jan; 38(1):56-61. PubMed ID: 25336290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins and Cataracts--a visual insight.
    Dobrzynski JM; Kostis JB
    Curr Atheroscler Rep; 2015; 17(2):477. PubMed ID: 25488134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statins--should we adjust the risk:benefit ratio?
    Lancet; 2011 Jan; 377(9763):354. PubMed ID: 21277425
    [No Abstract]   [Full Text] [Related]  

  • 54. Does statin use cause memory decline in the elderly?
    Samaras K; Brodaty H; Sachdev PS
    Trends Cardiovasc Med; 2016 Aug; 26(6):550-65. PubMed ID: 27177529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statin therapy and cardiovascular outcomes after coronary revascularization in the elderly.
    Katsiki N; Athyros VG; Mikhailidis DP
    Atherosclerosis; 2015 Feb; 238(2):182-4. PubMed ID: 25528425
    [No Abstract]   [Full Text] [Related]  

  • 56. Statin treatment reduces the risk of death among elderly frail patients: evidence from a large population-based cohort.
    Rea F; Mancia G; Corrao G
    Eur J Prev Cardiol; 2022 Feb; 28(17):1885-1894. PubMed ID: 33624076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choosing statins: a review to guide clinical practice.
    de Pádua Borges R; Degobi NAH; Bertoluci MC
    Arch Endocrinol Metab; 2021 Nov; 64(6):639-653. PubMed ID: 33166435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial treatment of bacterial infections in frail elderly patients: the difficult balance between efficacy, safety and tolerability.
    Pea F
    Curr Opin Pharmacol; 2015 Oct; 24():18-22. PubMed ID: 26141569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The genomic potential of the Aspirin in Reducing Events in the Elderly and Statins in Reducing Events in the Elderly studies.
    Lacaze P; Woods R; Zoungas S; McNeil J; ; ;
    Intern Med J; 2017 Apr; 47(4):461-463. PubMed ID: 28401726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACP Journal Club. Review: Statins reduce mortality and major vascular events in patients with no history of CV disease.
    Elley CR
    Ann Intern Med; 2013 Jul; 159(2):JC2. PubMed ID: 23856700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.